Advertisement

Transcatheter Aortic Valve Implantation: Abbott Portico

  • Carmelo Sgroi
  • Claudia Ina Tamburino
  • Martina Patanè
Chapter

Abstract

The Portico (St. Jude Medical) valve (Fig. 24.1a) is a self-expanding transcatheter aortic prosthesis that was clinically evaluated in the Portico CE trial. In this prospective, multicenter study, safety, and performance of the Portico system (23 and 25 mm valves delivered through 18 Fr transfemoral resheathable delivery system) were tested on 100 patients with severe symptomatic aortic stenosis, 50 for each valve size. The results through 12 months showed that the Portico system produces clinically significant and sustained improvements in patient outcomes. Additionally, this study establishes an excellent safety profile at 30 days with the Portico system in terms of mortality, permanent pacemaker rate, moderate/severe paravalvular leak (PVL), major stroke rate, and major vascular complications. The good hemodynamic results were sustained up to 12 months, with the mean aortic gradient constantly stable at about 9.9 mmHg and valve area at 1.6 cm2. The functional NYHA class remained improved and remained stable at follow-up [1].

References

  1. 1.
    Manoharan G. Portico CE Trial Assessment of the St. Jude Medical Portico Transcatheter Aortic Valve Implant and the Transfemoral Delivery System. EuroPCR 2014. Paris. 20–23, 2014. N = 100.Google Scholar
  2. 2.
    Vietmeier K, Principal R&D Engineer, St. Jude Medical.Google Scholar
  3. 3.
    Frater RWM, Seifter E, Liao K, et al. In: Gabbay S, Wheatley D, editors. Advances in anticalcific and antidegenerative treatment of heart valve bioprostheses, vol. 8. 1st ed. Austin: Silent Partners Inc.; 1997. p. 105–13.Google Scholar
  4. 4.
    Kelly SJ, Ogle MF, Carlyle WC, et al. Biocompatibility and calcification of bioprosthetic heart valves. Society for Biomaterials, Sixth World Biomaterials Congress Transaction, 2000;13534.Google Scholar
  5. 5.
    Vyavahare N, Hirsch D, Lerner E, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: efficacy and mechanisms. Circulation. 1997;95(2):479–88.CrossRefPubMedGoogle Scholar
  6. 6.
    Vyavahare N, Hirsch D, Lerner E, et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998;40(4):577–85.CrossRefPubMedGoogle Scholar
  7. 7.
    Barbanti M, Petronio AS, Capodanno D, et al. Impact of balloon post-dilation on clinical outcomes after transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv. 2014;7:1014–21.Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Carmelo Sgroi
    • 1
  • Claudia Ina Tamburino
    • 1
  • Martina Patanè
    • 1
  1. 1.Ferrarotto Hospital, University of CataniaCataniaItaly

Personalised recommendations